Cross-fund · 5 holders
CLDX
CELLDEX THERAPEUTICS INC NEW
CUSIP 15117B202
5
Tracked holders
$429.6M
Aggregate value
14,123,675
Shares
5
Active funds
Funds holding CLDX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $170.3M | — | -81,930 | -1.5% |
| Vanguard | Institutional | Q4 2025 | $109.4M | — | +72,817 | +1.8% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $102.5M | 0.13% | +1,471,582 | +83.7% |
| Millennium | Multi-Strategy | Q1 2026 | $39.8M | 0.02% | +40,827 | +3.4% |
| Citadel | Multi-Strategy | Q1 2026 | $7.7M | — | +156,811 | +182.1% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.